Orthofix Medical Inc. (OFIX): Price and Financial Metrics


Orthofix Medical Inc. (OFIX)

Today's Latest Price: $38.14 USD

0.53 (-1.37%)

Updated Nov 25 4:00pm

Add OFIX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

OFIX Stock Summary

  • For OFIX, its debt to operating expenses ratio is greater than that reported by just 9.79% of US equities we're observing.
  • In terms of twelve month growth in earnings before interest and taxes, Orthofix Medical Inc is reporting a growth rate of -104.31%; that's higher than just 18.39% of US stocks.
  • In terms of volatility of its share price, OFIX is more volatile than just 13.59% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Orthofix Medical Inc, a group of peers worth examining would be IRIX, ISR, CSPI, PMD, and CCF.
  • Visit OFIX's SEC page to see the company's official filings. To visit the company's web site, go to www.orthofix.com.

OFIX Stock Price Chart Interactive Chart >

Price chart for OFIX

OFIX Price/Volume Stats

Current price $38.14 52-week high $47.91
Prev. close $38.67 52-week low $22.11
Day low $37.46 Volume 167,600
Day high $39.11 Avg. volume 134,679
50-day MA $33.62 Dividend yield N/A
200-day MA $32.71 Market Cap 737.40M

Orthofix Medical Inc. (OFIX) Company Bio


Orthofix International provides reconstructive and regenerative orthopedic and spine solutions to physicians. It operates through four segments: BioStim, Biologics, Extremity Fixation, and Spine Fixation. The company was founded in 1987 and is based in Willemstad, Curaçao.

OFIX Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target: Forecasted Gain:
$38.14$23.14 -36%

Below please find a table outlining a discounted cash flow forecast for OFIX, in which we model out valuation assuming a variety of terminal growth rates. To summarize, we found that Orthofix Medical Inc ranked in the 37th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. In terms of the factors that were most noteworthy in this DCF analysis for OFIX, they are:

  • The company's balance sheet shows it gets 97% of its capital from equity, and 3% of its capital from debt. Notably, its equity weight is greater than 78.16% of US equities in the Healthcare sector yielding a positive free cash flow.
  • The business' balance sheet suggests that 3% of the company's capital is sourced from debt; this is greater than merely 12.12% of the free cash flow producing stocks we're observing.
  • Orthofix Medical Inc's effective tax rate, as measured by taxes paid relative to net income, is at 103 -- greater than 97.37% of US stocks with positive free cash flow.


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-37%
1%-37%
2%-36%
3%-35%
4%-35%
5%-34%

NVS, EDAP, HZNP, CRL, and PKI can be thought of as valuation peers to OFIX, in the sense that they are in the Healthcare sector and have a similar price forecast based on DCF valuation.


OFIX Latest News Stream


Event/Time News Detail
Loading, please wait...

OFIX Latest Social Stream


Loading social stream, please wait...

View Full OFIX Social Stream

Latest OFIX News From Around the Web

Below are the latest news stories about Orthofix Medical Inc that investors may wish to consider to help them evaluate OFIX as an investment opportunity.

Earnings Preview: Orthofix (OFIX) Q2 Earnings Expected to Decline

Orthofix (OFIX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 30, 2020

Orthofix Schedules Second Quarter 2020 Earnings Release and Conference Call for August 6, 2020

Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company focused on musculoskeletal products and therapies, today announced that it plans to release financial results for the second quarter 2020 before market open on Thursday, August 6, 2020. Jon Serbousek, President and Chief Executive Officer, and Doug Rice, Chief Financial Officer, will host a conference call and webcast to review the Company’s results at 8:30 a.m. ET the same day.

Yahoo | July 27, 2020

Orthofix JuniOrtho Plating System Gets Regulatory Clearances

Orthofix (OFIX) rides high on dual regulatory clearances for its deformity correction system, thus solidifying its pediatric orthopedics portfolio.

Yahoo | July 21, 2020

If You Had Bought Orthofix Medical's (NASDAQ:OFIX) Shares A Year Ago You Would Be Down 37%

Investors can approximate the average market return by buying an index fund. But if you buy individual stocks, you can...

Yahoo | July 20, 2020

Orthofix Receives FDA Clearance and CE Mark for the JuniOrtho Plating System

Orthofix's JuniOrtho Plating System for pediatric deformity correction and trauma reconstruction receives FDA clearance and CE Mark approval.

Yahoo | July 20, 2020

Read More 'OFIX' Stories Here

OFIX Price Returns

1-mo 17.39%
3-mo 24.23%
6-mo 11.91%
1-year -15.62%
3-year -28.86%
5-year -5.97%
YTD -17.41%
2019 -12.02%
2018 -4.04%
2017 51.19%
2016 -7.73%
2015 30.44%

Continue Researching OFIX

Here are a few links from around the web to help you further your research on Orthofix Medical Inc's stock as an investment opportunity:

Orthofix Medical Inc (OFIX) Stock Price | Nasdaq
Orthofix Medical Inc (OFIX) Stock Quote, History and News - Yahoo Finance
Orthofix Medical Inc (OFIX) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.905 seconds.